AtonRa Partners Buys Lightspeed Commerce Inc, The Descartes Systems Group Inc, Legend Biotech Corp, Sells ACADIA Pharmaceuticals Inc, Stable Road Acquisition Corp, Seres Therapeutics Inc

• New Purchases: LSPD, DSGX, LEGN, RKLB, BRKR, ASTR,
• Added Positions: PACB, BYND, PYPL, NTLA, SQ, SWAV, SEDG, PODD, GH, NRIX, ABMD, DXCM, RUN, TPIC, NSTG, TMO, TSLA, VEEV, NIO, WOLF, A, GPN, XYL, ENPH, SPCE, INSP, AMD, ECL, FISV, NVDA, SPWR, TTEK, EW, LSCC, FSLR, FOUR, TDOC, TWST, AXNX, CRWD, TXG, NET, DDD, FIS, MRVL, MU, FTNT, EVBG, KYMR, EXAS, BABA, ZS, TENB, PLTR, UPST, ALNY, SGEN, PANW, IQV, XLRN, TWLO, OKTA, DT, BFLY, RIOT, BIDU, BIIB, INTU, NBIX, TER, TRMB, MAXR, NOW, VRNS, CTLT, BPMC, ALRM, QTRX, SDGR, BNR, SNOW, IIVI, TDY, ZBRA, IRDM, BAH, RARE, BKI, RPD, FSLY, CRNC, BLI, SOFI, SOFI, MANT, EBS, GWRE, BL, ADPT, AMWL, AFRM, GOCO, LU,
• Reduced Positions: BNTX, ABT, FATE, MRNA, SHOP,
• Sold Out: ACAD, SRAC, MCRB,

For the details of AtonRa Partners's stock buys and sells, go to https://www.gurufocus.com/guru/atonra+partners/current-portfolio/portfolio

1. PayPal Holdings Inc (PYPL) - 33,314 shares, 2.90% of the total portfolio. Shares added by 10.93%
2. Square Inc (SQ) - 34,550 shares, 2.77% of the total portfolio. Shares added by 10.71%
3. Upstart Holdings Inc (UPST) - 23,852 shares, 2.52% of the total portfolio. Shares added by 2.13%
4. ShockWave Medical Inc (SWAV) - 34,615 shares, 2.38% of the total portfolio. Shares added by 10.37%
5. SolarEdge Technologies Inc (SEDG) - 26,106 shares, 2.31% of the total portfolio. Shares added by 10.18%

AtonRa Partners initiated holding in Lightspeed Commerce Inc. The purchase prices were between $77.62 and $124.41, with an estimated average price of $99.42. The stock is now traded at around $69.390000. The impact to a portfolio due to this purchase was 1.7%. The holding were 52,877 shares as of 2021-09-30.

AtonRa Partners initiated holding in The Descartes Systems Group Inc. The purchase prices were between $68.46 and $86.25, with an estimated average price of $75.74. The stock is now traded at around $88.240000. The impact to a portfolio due to this purchase was 1.09%. The holding were 40,000 shares as of 2021-09-30.

AtonRa Partners initiated holding in Legend Biotech Corp. The purchase prices were between $35.31 and $50.56, with an estimated average price of $41.56. The stock is now traded at around $49.110000. The impact to a portfolio due to this purchase was 0.57%. The holding were 33,493 shares as of 2021-09-30.

AtonRa Partners initiated holding in Rocket Lab USA Inc. The purchase prices were between $9.96 and $20.72, with an estimated average price of $14.04. The stock is now traded at around $14.290000. The impact to a portfolio due to this purchase was 0.54%. The holding were 99,422 shares as of 2021-09-30.

AtonRa Partners initiated holding in Bruker Corp. The purchase prices were between $76.52 and $91.36, with an estimated average price of $83.18. The stock is now traded at around $82.420000. The impact to a portfolio due to this purchase was 0.39%. The holding were 15,067 shares as of 2021-09-30.

AtonRa Partners initiated holding in Astra Space Inc. The purchase prices were between $8.25 and $15.47, with an estimated average price of $10.27. The stock is now traded at around $10.560000. The impact to a portfolio due to this purchase was 0.21%. The holding were 71,928 shares as of 2021-09-30.

AtonRa Partners added to a holding in Pacific Biosciences of California Inc by 63.36%. The purchase prices were between $24.86 and $35.02, with an estimated average price of $29.71. The stock is now traded at around $26.700000. The impact to a portfolio due to this purchase was 0.31%. The holding were 94,300 shares as of 2021-09-30.

AtonRa Partners added to a holding in Beyond Meat Inc by 36.53%. The purchase prices were between $105.26 and $152.99, with an estimated average price of $122.64. The stock is now traded at around $83.820000. The impact to a portfolio due to this purchase was 0.31%. The holding were 32,276 shares as of 2021-09-30.

AtonRa Partners added to a holding in Intellia Therapeutics Inc by 32.92%. The purchase prices were between $132.37 and $176.78, with an estimated average price of $151.97. The stock is now traded at around $133.540000. The impact to a portfolio due to this purchase was 0.29%. The holding were 26,153 shares as of 2021-09-30.

AtonRa Partners added to a holding in Nurix Therapeutics Inc by 70.31%. The purchase prices were between $22.71 and $36.69, with an estimated average price of $30.82. The stock is now traded at around $33.920000. The impact to a portfolio due to this purchase was 0.17%. The holding were 40,212 shares as of 2021-09-30.

AtonRa Partners added to a holding in NanoString Technologies Inc by 76.13%. The purchase prices were between $46.1 and $63.75, with an estimated average price of $57.65. The stock is now traded at around $47.160000. The impact to a portfolio due to this purchase was 0.13%. The holding were 18,805 shares as of 2021-09-30.

AtonRa Partners sold out a holding in ACADIA Pharmaceuticals Inc. The sale prices were between $15.78 and $24.77, with an estimated average price of $19.31.

AtonRa Partners sold out a holding in Stable Road Acquisition Corp. The sale prices were between $9.51 and $14.07, with an estimated average price of $11.09.

AtonRa Partners sold out a holding in Seres Therapeutics Inc. The sale prices were between $5.46 and $22.6, with an estimated average price of $9.91.